Clinical Trial Update: Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating montelukast sodium (MK0476) for asthma and perennial allergic rhinitis symptoms in response to cat exposure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma, Bronchial, Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED